Stock NVOS NOVO INTEGRATED SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Novo Integrated Sciences, Inc.

Equities

NVOS

US67011T3005

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.6171 USD -8.65% Intraday chart for Novo Integrated Sciences, Inc. +19.83% -24.84%
Apr. 15 Earnings Flash (NVOS) NOVO INTEGRATED SCIENCES Reports Q2 Revenue $3.2M MT
Apr. 15 Novo Integrated Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI

Business Summary

Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Number of employees: 179

Sales per Business

USD in Million2022Weight2023Weight Delta
Healthcare Services
65.4 %
8 71.5 % 8 65.4 % -2.04%
Product
34.5 %
3 28.4 % 4 34.5 % +29.93%
Corporate
0.1 %
0 0.0 % 0 0.1 % +204.94%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
12 100.0 % 13 100.0 % +7.11%

Managers

Managers TitleAgeSince
Robert Mattacchione CEO
 Chief Executive Officer 56 18-10-17
Vivek Sethi DFI
 Director of Finance/CFO 38 23-07-06
Robert Oliva PSD
 President 60 Feb. 14
Joseph M. Chalil CTO
 Chief Tech/Sci/R&D Officer - 21-03-31
Indrajit Sinha CTO
 Chief Tech/Sci/R&D Officer - 21-06-23
Christopher David COO
 Chief Operating Officer 65 14-08-12
Emily Mattacchione TRE
 Treasurer 43 18-03-14

Members of the board

Members of the board TitleAgeSince
Michael Pope BRD
 Director/Board Member 43 21-01-25
Christopher David COO
 Chief Operating Officer 65 14-08-12
Sarfaraz Ali BRD
 Director/Board Member 42 22-06-29
Robert Mattacchione CEO
 Chief Executive Officer 56 18-10-17
Alex Flesias BRD
 Director/Board Member 49 21-01-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,054,523 17,755,470 ( 93.18 %) 0 93.18 %

Shareholders

NameEquities%Valuation
Robert Mattacchione
7.273 %
1,290,858 7.273 % 628 648 $
BlackRock Institutional Trust Co. NA
1.645 %
291,921 1.645 % 142 166 $
Vanguard Global Advisers LLC
1.407 %
249,632 1.407 % 121 571 $
Geode Capital Management LLC
0.7208 %
127,929 0.7208 % 62 301 $
Citadel Securities GP LLC
0.6573 %
116,659 0.6573 % 56 813 $
Virtu Financial LLC
0.4857 %
86,197 0.4857 % 41 978 $
STATE STREET CORPORATION
0.1875 %
33,280 0.1875 % 16 207 $
Northern Trust Investments, Inc.(Investment Management)
0.1572 %
27,905 0.1572 % 13 590 $
Jane Street Group LLC
0.0909 %
16,132 0.0909 % 7 856 $
XTX Topco Ltd.
0.0697 %
12,368 0.0697 % 6 023 $

Company contact information

Novo Integrated Sciences, Inc.

11120 NE 2nd Street Suite 100

98004, Bellevue

+

http://novointegrated.com
address Novo Integrated Sciences, Inc.(NVOS)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Other Healthcare Facilities & Services

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
NOVO INTEGRATED SCIENCES, INC. Stock Novo Integrated Sciences, Inc.
-24.84% 11.76M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.25% 85.35B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.46% 81.95B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.37% 28.99B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.40% 16.98B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.36% 16.85B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.22% 15.35B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.32% 12.42B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.34% 11.88B
DAVITA INC. Stock DaVita Inc.
+32.69% 12.19B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. NVOS Stock
  4. Company Novo Integrated Sciences, Inc.